2-[(5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oyl]-sn-glycero-3-phosphocholine

Term ID

CHEBI:137585

Synonyms

(2R)-2-{[(5Z,11alpha,13E,15S)-11,15-dihydroxy-1,9-dioxoprosta-5,13-dien-1-yl]oxy}-3-hydroxypropyl 2-(trimethylazaniumyl)ethyl phosphate
2-(prostaglandin E2)-LPC
2-(prostaglandin E2)-sn-glycero-3-phosphocholine
2-[9-oxo-(11R,15S)-dihydroxy-(5Z,13E)-prostadienoyl]-sn-glycero-3-phosphocholine

Definition

A 2-acyl-sn-glycero-3-phosphocholine in which the acyl group is specified as (5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oyl

References

Ontology

ChEBI ( EBI )

Relationships

is a type of: 2-acyl-sn-glycero-3-phosphocholine oxidized 2-acyl-sn-glycero-3-phosphocholine zwitterion prostanoid

2-acyl-sn-glycero-3-phosphocholine oxidized 2-acyl-sn-glycero-3-phosphocholine zwitterion prostanoid Show first 5 Terms
has_functional_parent: prostaglandin E2

prostaglandin E2 Show first 5 Terms
has_role: human xenobiotic metabolite mouse metabolite

human xenobiotic metabolite mouse metabolite Show first 5 Terms

Phenotype

Phenotype resulting from 2-[(5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oyl]-sn-glycero-3-phosphocholine

Phenotype where environments contain 2-[(5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oyl]-sn-glycero-3-phosphocholine

Phenotype modified by environments containing 2-[(5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oyl]-sn-glycero-3-phosphocholine

Human Disease Model